Astria Therapeutics, Inc. (ATXS) Tops Q3 EPS by 85c

Astria Therapeutics, Inc. (NASDAQ: ATXS) reported Q3 EPS of $, $0.85 better than the analyst estimate of ($0.85).

For earnings history and earnings-related data on Astria Therapeutics, Inc. (ATXS) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue